BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $212,000 | -33.5% | 2,466 | -34.7% | 0.01% | -40.0% |
| Q1 2021 | $319,000 | +2.2% | 3,777 | -2.8% | 0.02% | +5.3% |
| Q4 2020 | $312,000 | 0.0% | 3,885 | 0.0% | 0.02% | -5.0% |
| Q3 2020 | $312,000 | -6.6% | 3,885 | 0.0% | 0.02% | -16.7% |
| Q2 2020 | $334,000 | +0.9% | 3,885 | -4.6% | 0.02% | -7.7% |
| Q1 2020 | $331,000 | -3.5% | 4,072 | -0.6% | 0.03% | +23.8% |
| Q4 2019 | $343,000 | -4.2% | 4,098 | 0.0% | 0.02% | -4.5% |
| Q3 2019 | $358,000 | +5.3% | 4,098 | -1.3% | 0.02% | +10.0% |
| Q2 2019 | $340,000 | +0.6% | 4,153 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $338,000 | -16.5% | 4,153 | -32.5% | 0.02% | -23.1% |
| Q4 2018 | $405,000 | -14.6% | 6,153 | 0.0% | 0.03% | 0.0% |
| Q3 2018 | $474,000 | -2.3% | 6,153 | -6.2% | 0.03% | -7.1% |
| Q2 2018 | $485,000 | -99.9% | 6,563 | +0.2% | 0.03% | +21.7% |
| Q1 2018 | $426,077,000 | +0.2% | 6,551 | -0.5% | 0.02% | +4.5% |
| Q4 2017 | $425,396,000 | +2.2% | 6,581 | -0.8% | 0.02% | -4.3% |
| Q3 2017 | $416,409,000 | +3.7% | 6,636 | +0.0% | 0.02% | 0.0% |
| Q2 2017 | $401,562,000 | +12.5% | 6,633 | -3.6% | 0.02% | +9.5% |
| Q1 2017 | $356,901,000 | +13.1% | 6,882 | -3.3% | 0.02% | +5.0% |
| Q4 2016 | $315,568,000 | -11.1% | 7,117 | -4.5% | 0.02% | -13.0% |
| Q3 2016 | $354,906,000 | -6.2% | 7,456 | -10.9% | 0.02% | -11.5% |
| Q2 2016 | $378,311,000 | +0.6% | 8,366 | -8.6% | 0.03% | 0.0% |
| Q1 2016 | $376,005,000 | -81.8% | 9,153 | -67.7% | 0.03% | -82.8% |
| Q4 2015 | $2,070,542,000 | +242.8% | 28,318 | +54.0% | 0.15% | +268.3% |
| Q3 2015 | $604,036,000 | -62.8% | 18,388 | -20.7% | 0.04% | -56.4% |
| Q2 2015 | $1,621,607,000 | -8.5% | 23,189 | -10.3% | 0.09% | -6.0% |
| Q1 2015 | $1,771,411,000 | -38.9% | 25,860 | -39.8% | 0.10% | -41.2% |
| Q4 2014 | $2,897,693,000 | +35.8% | 42,983 | +44.6% | 0.17% | +31.8% |
| Q3 2014 | $2,133,937,000 | -11.4% | 29,733 | -5.7% | 0.13% | -8.5% |
| Q2 2014 | $2,408,580,000 | -2.4% | 31,516 | -6.0% | 0.14% | -7.8% |
| Q1 2014 | $2,467,305,000 | +4.3% | 33,534 | -1.4% | 0.15% | -1.3% |
| Q4 2013 | $2,365,256,000 | -2.1% | 34,008 | -7.5% | 0.16% | -13.4% |
| Q3 2013 | $2,415,093,000 | -4.3% | 36,765 | +0.9% | 0.18% | -11.4% |
| Q2 2013 | $2,522,813,000 | – | 36,420 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |